Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hoogeboom, Baukje Nynke
28  Ergebnisse:
Personensuche X
?
1

Oncolytic alphavirus replicons mediated recruitment and act..:

Bhatt, Darshak K. ; Meuleman, Saskia L. ; Hoogeboom, Baukje Nynke.
iScience.  27 (2024)  3 - p. 109253 , 2024
Link: https://doi.org/10.1016/..
 
?
2

An in vitro CD8 T-cell priming assay enables epitope select..:

Koutsoumpli, Georgia ; Stasiukonyte, Neringa ; Hoogeboom, Baukje Nynke.
Vaccine.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

First-in-Human Phase I Clinical Trial of an SFV-Based RNA R..:

Komdeur, Fenne L. ; Singh, Amrita ; van de Wall, Stephanie...
Molecular Therapy.  29 (2021)  2 - p. 611-625 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Alphavirus-based hepatitis C virus therapeutic vaccines: ca..:

Koutsoumpli, Georgia ; Ip, Peng Peng ; Schepel, Ilona...
Therapeutic Advances in Vaccines and Immunotherapy.  7 (2019)  - p. 251513551987467 , 2019
Link: https://doi.org/10.1177/..
 
?
5

A rationally designed combined treatment with an alphavirus..:

Draghiciu, Oana ; Boerma, Annemarie ; Hoogeboom, Baukje Nynke..
OncoImmunology.  4 (2015)  10 - p. e1029699 , 2015
Link: https://doi.org/10.1080/..
 
?
6

Therapeutic immunization and local low‐dose tumor irradiati..:

Draghiciu, Oana ; Walczak, Mateusz ; Hoogeboom, Baukje Nynke...
International Journal of Cancer.  134 (2013)  4 - p. 859-872 , 2013
Link: https://doi.org/10.1002/..
 
?
7

Role of T cell competition in the induction of cytotoxic T ..:

Lambeck, Annechien J.A. ; Nijman, Hans W. ; Hoogeboom, Baukje Nynke...
Vaccine.  28 (2010)  26 - p. 4275-4282 , 2010
Link: https://doi.org/10.1016/..
 
?
8

Enhancement of human papilloma virus type 16 E7 specific T ..:

Visser, Jeroen ; van Baarle, Debbie ; Hoogeboom, Baukje Nynke...
International Journal of Cancer.  118 (2006)  10 - p. 2529-2537 , 2006
Link: https://doi.org/10.1002/..
 
?
9

HLA Class I Alleles and Cervical Neoplasia:

Visser, Jeroen T. J. ; Hoogeboom, Baukje Nynke ; Reesink-Peters, Nathalie...
The Journal of Infectious Diseases.  187 (2003)  10 - p. 1675-1676 , 2003
Link: https://www.jstor.org/st..
 
?
10

HLA Class I Alleles and Cervical Neoplasia:

Visser, Jeroen T. J. ; Hoogeboom, Baukje Nynke ; Reesink‐Peters, Nathalie...
The Journal of Infectious Diseases.  187 (2003)  10 - p. 1675-1676 , 2003
Link: https://doi.org/10.1086/..
 
?
11

Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Enc..:

Van de Wall, Stephanie ; Walczak, Mateusz ; Van Rooij, Nienke...
Vaccines.  3 (2015)  2 - p. 221-238 , 2015
Link: https://doi.org/10.3390/..
 
?
12

Heterologous Prime-Boost Immunizations with a Virosomal and..:

Walczak, Mateusz ; de Mare, Arjan ; Riezebos-Brilman, Annelies...
Molecular Pharmaceutics.  8 (2010)  1 - p. 65-77 , 2010
Link: https://doi.org/10.1021/..
 
?
13

Prognostic significance of tumor-infiltrating T-lymphocytes..:

Leffers, Ninke ; Gooden, Marloes J. M. ; de Jong, Renske A....
Cancer Immunology, Immunotherapy.  58 (2008)  3 - p. 449-459 , 2008
Link: https://doi.org/10.1007/..
 
?
14

First-in-Human Phase I Clinical Trial of an SFV-Based RNA R..:

Komdeur, Fenne L ; Singh, Amrita ; van de Wall, Stephanie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854293/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

First-in-Human Phase I Clinical Trial of an SFV-Based RNA R..:

Komdeur, Fenne L ; Singh, Amrita ; van de Wall, Stephanie...
https://research.rug.nl/en/publications/5172de71-9650-4d26-b08d-9a20ba7f7564.  , 2021
Link: https://hdl.handle.net/1..
 
1-15